GWAS |
- Alzheimer's disease ( 34099642)
- Cerebrospinal fluid α-synuclein levels ( 29959729)
- Glaucoma (primary open-angle) ( 33627673)
- HDL cholesterol levels in HIV infection ( 33109212)
- Longitudinal change in brain amyloid plaque burden ( 26268530)
- Spatial processing ( 31596458)
|
- Acute lymphoblastic leukemia (childhood) ( 23512250)
- Area under the curve of insulin levels ( 24699409)
- Birth weight ( 31043758)
- Blood pressure (smoking interaction) ( 25189868)
- Body mass index ( 26426971)
- Body mass index (age <50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Brain morphology (MOSTest) ( 32665545)
- Chronotype ( 30696823)
- Corpus callosum mid-anterior volume ( 31530798)
- Corrected insulin response ( 24699409)
- Corrected insulin response adjusted for insulin sensitivity index ( 24699409)
- Diastolic blood pressure ( 30224653)
- Eosinophil counts ( 32888494 27863252)
- Estimated glomerular filtration rate ( 31152163 31015462)
- Fasting blood glucose ( 22581228)
- Fasting blood glucose (BMI interaction) ( 22581228)
- Fasting glucose ( 33402679 34059833)
- Fasting insulin ( 34059833)
- Femoral neck bone mineral density ( 22504420)
- Fractures ( 30158200)
- Heel bone mineral density ( 30598549)
- Hip circumference adjusted for BMI ( 34021172)
- Incremental insulin ( 24699409)
- Insulin levels adjusted for BMI ( 24699409)
- Insulin-related traits (multivariate analysis) ( 32002517)
- Mean corpuscular volume ( 32888494)
- Mean reticulocyte volume ( 32888494)
- Metabolite levels ( 23823483)
- Morning person ( 30696823)
- Ratio of the area under the curve for insulin and the area under the curve for glucose ( 24699409)
- Response to zileuton treatment in asthma (FEV1 change interaction) ( 26031901)
- Schizophrenia (treatment resistant) ( 25223841)
- Subcortical volume (MOSTest) ( 32665545)
- Sum eosinophil basophil counts ( 27863252)
- Systemic sclerosis ( 21779181)
- Total body bone mineral density ( 29304378)
- Waist circumference adjusted for body mass index ( 34021172)
|